AU Patent

AU2004268024B2 — Novel crystalline forms of a phosphoric acid salt of a dipeptidyl peptidase-IV inhibitor

Assigned to Merck Sharp and Dohme LLC · Expires 2007-07-12 · 19y expired

What this patent protects

Patent listed against Steglatro.

Drugs covered by this patent

Patent Metadata

Patent number
AU2004268024B2
Jurisdiction
AU
Classification
—
Expires
2007-07-12
Drug substance claim
No
Drug product claim
No
Assignee
Merck Sharp and Dohme LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.